קולטנים רזרביים

Spare receptors are unoccupied receptors that remain unused even when an agonist produces a maximal biological response. Cells maintain spare receptors as functional reserves, allowing them to economically use low concentrations of endogenous agonists such as hormones and neurotransmitters. This mechanism ensures cells can generate full responses without requiring all receptors to be activated, providing efficiency and sensitivity to signaling molecules.

Spare receptors amplify signals through two mechanisms. First, a single agonist-receptor complex can activate multiple downstream effector proteins, so receptor numbers exceed available effector molecules. Second, activated effector molecules continue interacting with target proteins even after the agonist-receptor complex dissociates. These mechanisms allow only a fraction of receptors to produce maximal response, leaving the rest unused and available for signal amplification.

Scientists detect spare receptors by comparing EC50 (drug concentration producing 50% maximum effect) with Kd (drug concentration occupying 50% of receptors). If EC50 is smaller than Kd, spare receptors are present. This comparison reveals that maximal effects occur with fewer than 100% of receptors occupied, indicating the existence of functional reserves that support signal amplification and cellular sensitivity.

When spare receptors are present, antagonists must occupy a larger proportion of total receptors to block agonist effects. For example, insulin receptors are 99% spare, so antagonists must occupy nearly all receptors to counteract insulin's response. In contrast, the heart has only 5-10% spare β-adrenoceptors, requiring lower antagonist concentrations. This relationship between spare receptor abundance and antagonist requirement reflects the functional reserve available for signal transduction.

Approximately 99% of insulin receptors are spare, meaning only a small fraction of activated receptors are needed to allow glucose uptake and meet cellular energy requirements. This high proportion of spare receptors makes cells extremely sensitive to small changes in insulin concentration, enabling precise regulation of blood glucose levels around the clock. The spare receptors act as a buffer, ensuring consistent metabolic response despite fluctuating hormone levels.

Maximal biological response does not require 100% receptor occupancy due to spare receptors and signal amplification mechanisms. One agonist-receptor complex can activate multiple effector molecules, and activated intermediary proteins continue signaling after the complex dissociates. This allows cells to achieve full response with partial receptor occupancy, demonstrating that biological efficacy depends on signal amplification rather than complete receptor saturation.

Spare receptors increase drug sensitivity by expanding the available receptor pool for drug-receptor interactions. With more unoccupied receptors present, the probability of drug molecules encountering and binding to receptors increases. This larger target pool makes cells more responsive to lower drug concentrations, enhancing the overall sensitivity of the cell to agonist drugs and allowing therapeutic effects at reduced doses.